Axonics Modulation Technologies Inc (AXNX)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

26 TECHNOLOGY DRIVE IRVINE, CA 92618

Axonics Modulation Technologies, Inc. operates as a medical technology company. The Company focuses on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation solutions which used to treat patients with overactive bladder, fecal incontinence, andurinary retention. Axonics Modulation Technologies serves patients globally.

View SEC Filings from AXNX instead.

View recent insider trading info

Funds Holding AXNX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AXNX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

395 Thousand total shares from 8 transactions

Exercise Derivative Conversion (M)

10 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CARREL MICHAEL H PRESIDENT, CEO, & DIRECTOR

  • Officer
  • Director
626,490 2020-01-14 3

COHEN RAYMOND W CHIEF EXECUTIVE OFFICER

608,391 2020-01-13 5

SAMA RINDA CHIEF OPERATING OFFICER

204,627 2020-01-02 8

DEAREN DANNY L. SEE REMARKS

48,491 2019-12-19 5

WOOCK JOHN CHIEF MARKETING OFFICER

0 2019-12-12 3

FORD ALFRED J JR CHIEF COMMERCIAL OFFICER

0 2019-12-12 2

ANDERA PARTNERS

BIODISCOVERY 4 FCPR

3,257,461 2019-11-22 1

PARDO GEOFF

  • FORMER 10% OWNER
0 2019-11-21 2

GILDE HEALTHCARE HOLDING B.V.

GILDE HEALTHCARE IV MANAGEMENT B.V.

COOPERATIEVE GILDE HEALTHCARE IV U.A.

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
0 2019-11-21 1

WISNIEWSKI RAPHAEL

3,257,461 2019-11-19 1

TAMMENOMS BAKKER JULIET

  • Director
0 2019-11-07 3

MALIK SHAHZAD

  • Director
0 2019-09-12 0

AMBLE ERIK

1,530,051 2019-08-22 3

MCNAMARA ROBERT E

13,167 2019-08-22 3

SNYDERMAN NANCY LYNN MD

9,083 2019-08-22 4

KIERNAN JANE E

7,083 2019-08-22 3

NOBLETT KAREN CHIEF MEDICAL OFFICER

54,124 2019-07-23 2

WILLIAMSON MICHAEL V. SVP, GENERAL COUNSEL

152,318 2019-07-01 3

MATHUR PRABODH SEE REMARKS

  • Officer
0 2019-01-30 1

JIANG GUANGQIANG CHIEF TECHNOLOGY OFFICER

  • Officer
0 2019-01-30 1

FORD ALFRED J JR CHIEF COMMERCIAL OFFICER

FORD ALFRED J JR CHIEF COMMERCIAL OFFICER

  • Officer
0 2019-01-30 2

PETROVICH JOHN GEORGE

  • Director
2,105,470 2018-12-06 0

KUANG ZHONG

ZAC & CLOUD HOLDINGS LTD

  • FORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2018-11-02 0

NEOMED INNOVATION V LTD

NEOMED INNOVATION V L.P.

  • FORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2018-11-02 0

ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH

  • FORMER 10% OWNER
No longer subject to file 2018-11-02 0

ADVENT LIFE SCIENCES LLP

ADVENT LIFE SCIENCES FUND II LP

  • FORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2018-11-02 0

LONGITUDE CAPITAL PARTNERS III, LLC

ENRIGHT PATRICK G

LONGITUDE VENTURE PARTNERS III, L.P.

  • 10% Owner
2,933,333 2018-11-02 0

CORMORANT ASSET MANAGEMENT, LP

CHEN BIHUA

CORMORANT GLOBAL HEALTHCARE GP, LLC

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

  • Director
  • 10% Owner
No longer subject to file 2018-10-31 0

CORMORANT ASSET MANAGEMENT, LP

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

CORMORANT PRIVATE HEALTHCARE FUND I, LP

CHEN BIHUA

  • Director
  • 10% Owner
0 2018-10-30 0

GILDE HEALTHCARE HOLDING B.V.

GILDE HEALTHCARE IV MANAGEMENT B.V.

  • 10% Owner
0 2018-10-30 1

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

COHEN RAYMOND W CHIEF EXECUTIVE OFFICER

2020-01-13 S 10,000 $31.98 d 608,391 608,391.00 direct yes

COHEN RAYMOND W CHIEF EXECUTIVE OFFICER

2020-01-13 M 10,000 $1.63 a 618,391 608,391.00 direct

COHEN RAYMOND W CHIEF EXECUTIVE OFFICER

2020-01-13 M 10,000 d 158,000 608,391.00 direct

SAMA RINDA CHIEF OPERATING OFFICER

2020-01-02 S 5,000 $27.42 d 200,627 204,627.00 direct yes

DEAREN DANNY L. SEE REMARKS

2019-12-19 S 30,000 $26.07 d 48,491 48,491.00 direct yes

WOOCK JOHN CHIEF MARKETING OFFICER

2019-12-12 A 5,435 a 5,435 0.00 direct

FORD ALFRED J JR CHIEF COMMERCIAL OFFICER

2019-12-12 A 7,065 a 7,065 0.00 direct

SAMA RINDA CHIEF OPERATING OFFICER

2019-12-12 A 9,239 a 9,239 0.00 direct

DEAREN DANNY L. SEE REMARKS

2019-12-12 A 13,043 a 13,043 0.00 direct

COHEN RAYMOND W CHIEF EXECUTIVE OFFICER

2019-12-12 A 27,173 a 27,173 0.00 direct

WOOCK JOHN CHIEF MARKETING OFFICER

2019-12-12 A 15,625 a 15,625 0.00 direct

FORD ALFRED J JR CHIEF COMMERCIAL OFFICER

2019-12-12 A 20,312 a 20,312 0.00 direct

SAMA RINDA CHIEF OPERATING OFFICER

2019-12-12 A 26,563 a 26,563 0.00 direct

DEAREN DANNY L. SEE REMARKS

2019-12-12 A 37,500 a 37,500 0.00 direct

COHEN RAYMOND W CHIEF EXECUTIVE OFFICER

2019-12-12 A 78,125 a 78,125 0.00 direct

WOOCK JOHN CHIEF MARKETING OFFICER

2019-12-12 A 5,435 a 5,435 0.00 direct

FORD ALFRED J JR CHIEF COMMERCIAL OFFICER

2019-12-12 A 7,065 a 7,065 0.00 direct

SAMA RINDA CHIEF OPERATING OFFICER

2019-12-12 A 9,239 a 9,239 0.00 direct

DEAREN DANNY L. SEE REMARKS

2019-12-12 A 13,043 a 13,043 0.00 direct

COHEN RAYMOND W CHIEF EXECUTIVE OFFICER

2019-12-12 A 27,173 a 27,173 0.00 direct

SAMA RINDA CHIEF OPERATING OFFICER

2019-12-05 S 5,000 $23.92 d 205,627 209,627.00 direct yes

WOOCK JOHN CHIEF MARKETING OFFICER

2019-12-02 S 14,500 $23.43 d 80,181 79,681.00 direct yes

WOOCK JOHN CHIEF MARKETING OFFICER

2019-12-02 S 500 $24.20 d 79,681 79,681.00 direct yes

ANDERA PARTNERS see footnote

BIODISCOVERY 4 FCPR see footnote

2019-11-22 S 300,000 $20.74 d 3,257,461 3,257,461.00 indirect

DEAREN DANNY L. SEE REMARKS

2019-11-21 S 30,000 $21.61 d 78,491 78,491.00 direct yes
Click here to report any possible errors with this stock listing.

Elevate your investments